SJS Investment Consulting’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20
Closed -$843 1657
2023
Q2
$843 Sell
20
-2
-9% -$81 ﹤0.01% 965
2023
Q1
$784 Buy
22
+7
+47% +$254 ﹤0.01% 991
2022
Q4
$550 Buy
15
+3
+25% +$119 ﹤0.01% 1191
2022
Q3
$1K Buy
+12
New +$775 ﹤0.01% 979
2022
Q1
$0 Buy
+4
New +$338 ﹤0.01% 1461

Other funds holding SYNH

SJS Investment Consulting's SYNH Position: Q3 2023 in Review

SJS Investment Consulting sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 20 shares — an estimated $843 sold.

SJS Investment Consulting first reported a position in SYNH in Q1 2022 and held it in 5 quarters. The position peaked at $1K in Q3 2022. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • SJS Investment Consulting reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • SJS Investment Consulting sold 20 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $843.
  • SJS Investment Consulting first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2022 and held it in 5 quarters.
  • SJS Investment Consulting's Syneos Health, Inc. Class A Common Stock position peaked at $1K in Q3 2022.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on SJS Investment Consulting's 13F filing for Q3 2023, filed 17 Oct 2023.